YB Urban Renewal Residential Development Ltd, formerly known as Cannassure Therapeutics Ltd, is an Israel-based urban renewal company. The Company is engaged mainly in urban renewal projects. In the urban renewal projects sector, the Company partakes in activities that aim to clear out areas of inner cities deemed to be neglected, unused and loosely maintained, in favor of new multifamily housing, business areas, as well as other developments improving the city landscape. The Firm aims to achieve economic, cultural and environmental renewal of the neglected inner city areas. The Company cooperates with a range of specialists in the field of urban renewal with knowledge and experience in urban planning and construction work.

Employees

Sector

Real Estate Development & Operations

More about the company

Quotes

Date	Price	Change	Volume
26-07-29	ILA 604.80	-1.75%	81

Delayed Quote TEL AVIV STOCK EXCHANGE

More quotes

Income Statement and Estimates

More financial data

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 06:28:33 2026-07-29 EDT			5-day change	1st Jan Change
604.80 ^ILa	-1.75%		0.00%	-16.98%

05-03	Y.B Urban Renewal - Residential Development Ltd Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-02	Y.B Urban Renewal - Residential Development Ltd Auditor Raises 'Going Concern' Doubt	CI

Market Cap	29.29M 0 9.6M 8.43M 7.85M 7.22M 13.53M 918M 13.76M 93.11M 36.45M 455M 36.05M 35.28M 1.57B	P/E 2024	-4.93x	P/E 2025	-9.22x
Enterprise Value	29.41M 0 9.64M 8.46M 7.88M 7.25M 13.59M 921M 13.82M 93.48M 36.59M 457M 36.2M 35.41M 1.58B	EV / Sales 2024	376x	EV / Sales 2025	-
Free-Float	54.18%	Yield 2024 *	-	Yield 2025	-

05-03	Y.B Urban Renewal - Residential Development Ltd Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-02	Y.B Urban Renewal - Residential Development Ltd Auditor Raises 'Going Concern' Doubt	CI
11-12	Y.B Urban Renewal - Residential Development Ltd announced that it expects to receive ILS 0.53001 million in funding	CI
25-09-10	Y.B Urban Renewal - Residential Development Ltd Reports Earnings Results for the Half Year Ended June 30, 2025	CI
24-09-01	Y.B Urban Renewal - Residential Development Ltd Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-07-11	Cannassure Therapeutics Ltd will Change its Name to Y.B URBAN RENEWAL - RESIDENTIAL DEVELOPMENT LTD	CI
24-03-27	Y.B Urban Renewal - Residential Development Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-26	Y.B Urban Renewal - Residential Development Ltd Auditor Raises 'Going Concern' Doubt	CI
23-08-31	Cannassure Therapeutics Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-03-26	Cannassure Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	CI
21-08-09	Cannassure Was Granted A Patent for an Oral Delivery Method of Cannabis and Cannabinoids Compositions by the Israel Patents Authority	CI

21-02-26	DanCann Pharma A/S : publishes Year-end report for 2020	AQ
21-01-18	Cannassure Therapeutics : DanCann Pharma's strategic partner, Cannassure Therapeutics Ltd., enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO® technology	AQ
21-01-18	Lipidor : and Cannassure enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO technology	AQ
20-12-15	DanCann Pharma A/S : enter exclusive agreement with Cannassure Therapeutics to be multinational distributor for Scandinavia (Denmark, Norway, Sweden, and Finland)	AQ
20-11-19	Lipidor : publishes interim report for Q3 2020	AQ

Y.B Urban Renewal - Residential Development Ltd Stock

Stocks

YBRD

IL0001110134

Real Estate Development & Operations

Valuation: Y.B Urban Renewal - Residential Development Ltd

Chart: Y.B Urban Renewal - Residential Development Ltd

Latest news : Y.B Urban Renewal - Residential Development Ltd

Press Releases: Y.B Urban Renewal - Residential Development Ltd

Quotes and Performance

Course Extremes

Managers and Directors: Y.B Urban Renewal - Residential Development Ltd

Other Real Estate Development & Operations

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	-1.75%
Current month	-3.69%
1 month	-5.72%
3 months	-17.05%
6 months	-20.78%
Current year	-16.98%

1 month	590	635
Current year	590	799
1 year	590	899
3 years	291	2,075
5 years	291	7,270
10 years	291	34,500

Manager	Title	Age	Since
Ada Bar Kama CEO	Chief Executive Officer	56	2022-03-30
Oren Attiya DFI	Director of Finance/CFO	44	-
Daniel Spira AUD	Comptroller/Controller/Auditor	72	2019-06-25

Director	Title	Age	Since
Nir Peles CHM	Chairman	53	2021-12-08
Shimon Bar-Kama BRD	Director/Board Member	74	2018-12-03
Varda Kalal BRD	Director/Board Member	58	2022-02-13

	2024	2025
Net sales	76K 0 24.92K 21.87K 20.36K 18.73K 35.11K 2.38M 35.71K 242K 94.55K 1.18M 93.54K 91.52K 4.08M	-
Net income	-3.68M -0 -1.2M -1.06M -985K -906K -1.7M -115M -1.73M -11.68M -4.57M -57.08M -4.52M -4.43M -197M	-3M -0 -982K -862K -803K -738K -1.38M -93.84M -1.41M -9.52M -3.73M -46.54M -3.69M -3.61M -161M
Net Debt	980K 0 321K 282K 263K 241K 453K 30.69M 460K 3.11M 1.22M 15.22M 1.21M 1.18M 52.59M	115K 0 37.7K 33.09K 30.81K 28.34K 53.12K 3.6M 54.03K 366K 143K 1.79M 142K 138K 6.17M

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
Y.B URBAN RENEWAL - RESIDENTIAL DEVELOPMENT LTD	-1.75%	0.00%	-20.63%	+59.58%	9.6M
SUN HUNG KAI PROPERTIES LIMITED	+0.33%	-0.90%	+27.86%	+24.45%	44.72B
CHINA RESOURCES LAND LIMITED	+1.55%	+2.16%	+13.10%	-5.54%	30.54B
MITSUBISHI ESTATE CO., LTD.	+1.23%	-2.47%	+46.12%	+136.04%	29.77B
EMAAR PROPERTIES	-1.96%	-2.14%	-28.93%	+62.43%	26.95B
MITSUI FUDOSAN CO., LTD.	+1.97%	+4.50%	+22.33%	+67.24%	26.23B
CK ASSET HOLDINGS LIMITED	+0.17%	+1.17%	+31.22%	+7.60%	21.58B
SUMITOMO REALTY & DEVELOPMENT CO., LTD.	+0.29%	-1.34%	+38.16%	+96.64%	21.05B
ALPHA DHABI HOLDING	-0.82%	-1.75%	-40.07%	-63.43%	20.04B
CHINA OVERSEAS LAND & INVESTMENT LIMITED	+2.39%	+2.77%	-4.72%	-25.27%	18.7B
Average	+0.34%	-0.69%	+8.44%	+35.97%	23.96B
Weighted average by Cap.	+0.57%	-0.89%	+14.23%	+37.05%